In the current issue of the JMDR...

  • Ancillary medicinal substance: EU consultation process for medical devices incorporating an ancillary medicinal substance
     
  • Australia: The Medical Technology Association of Australia's (MTAA's) view on the current regulatory reforms in Australia
     
  • IVDs: The European Diagnostics Manufacturers Association's (EDMA's) view on the future of in vitro diagnostic (IVD) legislation in Europe
     
  • Clinical trials: The evolving regulation of medical device clinical trials in the USA
     
  • Tissues of animal origin: A critical examination of Commission Regulation (EU) No 722/2012 on medical devices utilising tissues of animal origin
     
  • Regulatory updates: Argentina, Australia, Brazil, Canada, China, the European Union, Germany, India, International, Japan, Kenya, Malaysia, Peru, the Philippines, Saudi Arabia, Singapore, South Korea, Sweden, Turkey, the UK, the Ukraine and the USA plus standards updates
     
  • Country Overview: summary of the medical device regulatory requirements in Bosnia & Herzegovina